Baxter pumps up lyophilization capacity at Halle plant

Baxter ($BAX) has once again expanded the freeze-drying capacity at its BioPharma Solutions contract manufacturing facility in Halle, Germany. Increased pharma demand for cytotoxic contract manufacturing prompted the investment, the company said. Report

Suggested Articles

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.

India’s Aurobindo, which has yet to close its $1 billion deal to buy 300 Sandoz products in the U.S., continues to rack up FDA issues.